SITIME Corp
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Unaudited Condensed Consolidated Financial Statements
Note 1. The Company and Basis of Presentation
SiTime Corporation (the “Company” or "SiTime") was incorporated in the State of Delaware in December 2003. The Company is a leading provider of Precision Timing solutions to the global electronics industry, providing the timing functionality that is needed for electronics to operate reliably and correctly. The Company's products have been designed to address a wide range of applications across a broad array of end markets. The Company operates a fabless business model and leverages its global network of distributors to address the broad set of end markets that it serves.
The accompanying interim condensed consolidated financial statements have been prepared in conformity with United States (U.S.) generally accepted accounting principles (GAAP) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X, and should be read in conjunction with the Company's audited consolidated financial statements and related notes thereto filed with the U.S. Securities and Exchange Commission (SEC) on Form 10-K for the fiscal year ended December 31, 2023. The interim financial statements are unaudited, but reflect all adjustments which are, in the opinion of management, of a normal, recurring nature necessary to provide a fair statement of results for the interim periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024, for any future year, or for any other future interim period.
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The significant areas requiring the use of management estimates and assumptions include revenue recognition, fair value of earnout liabilities, estimate of reserve for excess and obsolete inventories, and sales reserves. Actual results could differ from those estimates.
Principles of Consolidation
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Significant Accounting Policies
The Company’s significant accounting policies are disclosed in the Company’s audited consolidated financial statements and related notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2023. There have been no changes to these accounting policies through September 30, 2024.
Recent Accounting Pronouncements
In November 2023, the FASB issued ASU No. 2023-07, “Improvements to Reportable Segment Disclosures (Topic 280)” in order to require disclosure of incremental segment information on an annual and interim basis for all public entities. The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items and interim disclosures of a reportable segment’s profit or loss and assets. The ASU is to be applied retrospectively to all prior periods presented in the financial statements and is effective for our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, with early adoption permitted. We do not expect the standard to have a material impact on our consolidated financial statements.
Note 2. Acquisitions
On December 1, 2023, we completed our acquisition of Aura's timing business and clock products, and an assembled workforce. The acquisition qualified as a business combination in accordance with ASC 805, Business Combinations and, accordingly, total consideration was first allocated to the fair value of assets acquired as of the date of acquisition, with the excess being recorded as goodwill. The acquisition date fair value of the purchase consideration was $259.2 million, which comprised the following:
| Estimated Fair Value | |
|---|---|
| (in thousands) | |
| Fixed consideration | $139,946 |
| Fair value of sales-based earnout liability | 102,278 |
| Settlement of pre-existing arrangement | 16,974 |
| Total purchase consideration | $259,198 |
The preliminary purchase consideration allocation to the assets acquired based on their respective estimated fair values as of the date of acquisition is as follows:
| Estimated Fair Value (Preliminary) | Estimated Useful Life | Financial Statement Line Item | |
|---|---|---|---|
| (in thousands) · (in years) | |||
| Developed technology | $96,700 | 5 to 8 years | Intangible assets, net |
| In-process research and development | 69,500 | N/A | Intangible assets, net |
| Assumed customer agreements | 5,900 | 4 years | Intangible assets, net |
| Goodwill | 87,098 | Indefinite | Goodwill |
| Total assets acquired | $259,198 | ||
Following are the supplemental consolidated financial results of the Company on an unaudited pro forma basis, as if the acquisition had been consummated on January 1, 2023:
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| Unaudited pro forma information | 2024 | 2023 | 2024 | 2023 |
| (in thousands) · (in thousands) | ||||
| Revenue | $57,698 | $35,300 | $134,586 | $102,520 |
| Net loss | $(19,315) | $(23,530) | $(74,788) | $(80,976) |
The supplemental pro forma information presents the combined results of operations for the three and nine months ended September 30, 2024 and 2023, as if the acquisition was completed on January 1, 2023, the first day of the fiscal year of 2023. The supplemental pro forma financial information presented above is not necessarily indicative of the financial position or results of operations that would have been realized if the acquisition had been completed on the date indicated. The supplemental pro forma financial information does not reflect synergies that might have been achieved, nor is it indicative of future operating results or financial position. The proforma financial information includes a $6.5 million nonrecurring adjustment related to acquisition costs.
Note 3. Fair Value Measurements
Cash equivalents
At September 30, 2024 and December 31, 2023, highly liquid money market funds of $0.4 million and $0.4 million, respectively, were valued using Level 1 of the fair value hierarchy, quoted prices in active markets for identical assets, and are included in cash equivalents.
Short-term investments in held-to-maturity securities
As of September 30, 2024 and December 31, 2023, the Company had purchased Treasury Bills with maturities ranging from 3 to 12 months, which the Company intends to hold until maturity and has classified as held-to-maturity securities. The held-to-maturity securities are recorded at amortized cost totaling $426.3 million including gross accrued interest of $10.9 million as of September 30, 2024. As of September 30, 2024, the fair value and gross unrealized loss on the held-to-maturity securities was $426.6 million and $0.2 million, respectively.
As of December 31, 2023, the amortized cost of the held-to-maturity securities totaled $518.7 million including gross accrued interest of $8.9 million. As of December 31, 2023, the fair value and gross unrealized loss on the held-to-maturity securities was $519.0 million and $0.3 million, respectively.
These treasury bills were valued using Level 1 of the fair value hierarchy, quoted prices in active markets for identical assets, and are included in short-term investments. The carrying value of our investments is reviewed quarterly for changes in circumstances or the occurrence of events that suggests an investment may not be fully recoverable.
Sales-based earnout liability
The estimated fair value of the sales-based earnout liability is determined using a Monte Carlo simulation model using significant unobservable fair value inputs and is therefore classified as a Level 3 measurement. The assumptions used in the calculation are based on the revenue projections over the term of the contingent earn-out period, expected volatility, and discount rate. The estimates of fair value are uncertain and changes in any of the estimated inputs used will result in significant adjustments to the fair value. As of September 30, 2024, the Company used a volatility rate of 20%, risk free rate ranging from 3.6% to 4.8%, and an expected term ranging from 0.13 years to 4.13 years.
The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities:
| Amount | |
|---|---|
| Fair value as of January 1, 2024 | $103,461 |
| Change in the fair value during the year recorded to acquisition related costs | 4,947 |
| Payments made during the period | (8,551) |
| Fair value as of September 30, 2024 | $99,857 |
There were no transfers between Level 1, Level 2, and Level 3 categories during any of the periods presented.
Note 4. Balance Sheet Components
Accounts Receivable, net
Accounts receivable, net consisted of the following:
| As of | |||
|---|---|---|---|
| September 30, 2024 | December 31, 2023 | December 31, 2022 | |
| (in thousands) | |||
| Accounts receivable, gross | $30,225 | $21,911 | $41,279 |
| Allowance for credit losses | (50) | (50) | (50) |
| Accounts receivable, net | $30,175 | $21,861 | $41,229 |
Inventories
Inventories consisted of the following:
| As of | ||
|---|---|---|
| September 30, 2024 | December 31, 2023 | |
| (in thousands) | ||
| Raw materials | $16,260 | $17,550 |
| Work in progress | 39,471 | 35,193 |
| Finished goods | 16,149 | 12,796 |
| Total inventories | $71,880 | $65,539 |
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
| As of | ||
|---|---|---|
| September 30, 2024 | December 31, 2023 | |
| (in thousands) | ||
| Prepaid expenses | $3,749 | $3,563 |
| Other current assets | 5,145 | 4,078 |
| Total prepaid expenses and other current assets | $8,894 | $7,641 |
Property and Equipment, net
Property and equipment, net consisted of the following:
| As of | ||
|---|---|---|
| September 30, 2024 | December 31, 2023 | |
| (in thousands) | ||
| Lab and manufacturing equipment | $94,402 | $80,772 |
| Computer equipment | 3,731 | 3,541 |
| Furniture and fixtures | 1,171 | 969 |
| Construction in progress | 18,227 | 5,978 |
| Leasehold improvements | 7,945 | 7,847 |
| 125,476 | 99,107 | |
| Accumulated depreciation | (55,787) | (44,422) |
| Total property and equipment, net | $69,689 | $54,685 |
Depreciation expense related to property and equipment was $4.0 million and $3.3 million for the three months ended September 30, 2024 and 2023, respectively, and $11.4 million and $9.8 million for the nine months ended September 30, 2024 and 2023, respectively.
Intangible Assets, net
Intangible assets, net consisted of the following:
| As of | ||||||
|---|---|---|---|---|---|---|
| September 30, 2024 · December 31, 2023 | ||||||
| (in thousands) | ||||||
| Gross Assets | Accumulated Amortization | Net Assets | Gross Assets | Accumulated Amortization | Net Assets | |
| Developed technology | $96,700 | $(7,371) | $89,329 | $96,700 | $(159) | $96,541 |
| Contract based royalty asset | $5,900 | $(1,229) | $4,671 | $5,900 | $(121) | $5,779 |
| Internal use software | $9,434 | $(9,434) | $— | $9,434 | $(9,234) | $200 |
| Purchased software | 15,464 | (11,569) | 3,895 | 15,110 | (10,051) | 5,059 |
| Total amortizable intangible assets | $127,498 | $(29,603) | $97,895 | $127,144 | $(19,565) | $107,579 |
| In-process research and development | $69,500 | $— | $69,500 | $69,500 | $— | $69,500 |
| Total intangible assets | $196,998 | $(29,603) | $167,395 | $196,644 | $(19,565) | $177,079 |
Amortization expense for intangible assets was $3.9 million and $0.7 million for the three months ended September 30, 2024 and 2023, respectively, and $10.0 million and $1.9 million for the nine months ended September 30, 2024 and 2023, respectively.
The estimated aggregate future amortization expense for intangible assets subject to amortization as of September 30, 2024 is summarized as below:
| (in thousands) | |
|---|---|
| 2024 (remainder) | $3,948 |
| 2025 | 15,381 |
| 2026 | 15,039 |
| 2027 | 14,670 |
| 2028 | 12,948 |
| 2029 and beyond | 35,909 |
| $97,895 | |
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following:
| As of | ||
|---|---|---|
| September 30, 2024 | December 31, 2023 | |
| (in thousands) | ||
| Accrued payroll and related benefits | $8,351 | $6,358 |
| Revenue reserves | 3,723 | 2,954 |
| Sales-based earnout liability, current | 18,060 | 19,733 |
| Acquisition consideration payable, current | 39,245 | 75,695 |
| Short term lease liability | 2,680 | 2,601 |
| Other accrued expenses | 4,917 | 5,363 |
| Total accrued expenses and other current liabilities | $76,976 | $112,704 |
The Company has consolidated the deferred non-recurring engineering services and accrued customer rebates into the Other accrued expenses line item above as the amounts are not significant. The prior period balance has been updated to reflect current period presentation.
Other Non-current Liabilities
Other non-current liabilities consisted of the following:
| As of | ||
|---|---|---|
| September 30, 2024 | December 31, 2023 | |
| (in thousands) | ||
| Sales-based earnout liability, non-current | $81,797 | $83,728 |
| Acquisition consideration payable, non-current | 1,000 | 33,086 |
| Long term lease liability | 3,951 | 5,423 |
| Total other non-current liabilities | $86,748 | $122,237 |
Note 5. Leases
The Company leases office space in California, Michigan, Malaysia, Japan, Taiwan, the Netherlands, Finland, Ukraine, and India, all under non-cancellable operating leases with various expiration dates through May 2029.
The remaining lease terms vary from a few months tofive years. For certain of its leases the Company has options to extend the lease term for periods varying fromone tofive years. These renewal options are not considered in the remaining lease term unless it is reasonably certain that the Company will exercise such options. The Company also has variable lease payments that are primarily comprised of common area maintenance and utility charges.
The table below presents the operating lease-related assets and liabilities recorded on the condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023:
| As of | ||
|---|---|---|
| September 30, 2024 | December 31, 2023 | |
| (in thousands) | ||
| Right-of-use assets | $6,927 | $8,262 |
| Lease liabilities included in accrued expenses and other current liabilities | 2,680 | 2,601 |
| Lease liabilities included in other non-current liabilities | 3,951 | 5,423 |
| Total operating lease liabilities | $6,631 | $8,024 |
| Weighted-average remaining lease term (years) | 2.6 | 3.1 |
| Weighted-average discount rate | 4.9% | 4.5% |
The table below presents certain information related to the lease costs for operating leases for the three and nine months ended September 30, 2024 and 2023:
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (in thousands) | ||||
| Operating lease cost | $794 | $754 | $2,295 | $2,272 |
| Short-term lease cost | 236 | 209 | 650 | 521 |
| Variable lease cost | 582 | 194 | 1,231 | 632 |
| Total lease cost | $1,612 | $1,157 | $4,176 | $3,425 |
Cash paid for operating lease liabilities was $0.8 million and $0.8 million for the three months ended September 30, 2024 and 2023, respectively.
Cash paid for operating lease liabilities was $2.4 million and $2.3 million for the nine months ended September 30, 2024 and 2023, respectively.
Operating Lease Cash Flows
The table below reconciles the undiscounted cash flows for each of the first five years and total of the remaining years to the operating lease liabilities recorded on the condensed consolidated balance sheet as of September 30, 2024:
| (in thousands) | |
|---|---|
| Remainder of 2024 | $825 |
| 2025 | 3,009 |
| 2026 | 2,350 |
| 2027 | 586 |
| 2028 | 232 |
| 2029 and beyond | 86 |
| Total minimum lease payments | 7,088 |
| Less: amount of lease payments representing interest | (457) |
| Present value of future minimum lease payments | 6,631 |
| Less: current obligations under leases | (2,680) |
| Long-term lease liabilities | $3,951 |
Note 6. Stockholders’ Equity
At-The-Market offering
On February 27, 2024, the Company entered into a Sales Agreement ("Sales Agreement"), with Stifel, Nicolaus & Company, Incorporated ("Stifel"), under which the Company may offer and sell from time to time at its sole discretion, up to an aggregate of 1,200,000 shares of its common stock, par value $0.0001 per share, through Stifel acting as its sales agent. The Company used the net proceeds from the shares of common stock offered and sold to replenish funds expended to satisfy anticipated tax withholding and remittance obligations related to the net settlement upon vesting of restricted stock unit awards (“RSU”) granted to employees under the equity incentive plans. The Company has filed a prospectus supplement pursuant to the Sales Agreement for the offer and sale of up to an aggregate of 1,200,000 shares of its common stock. Subject to the terms and conditions of the Sales Agreement, Stifel will sell the common stock from time to time, based upon instructions from the Company. The Company agreed to pay Stifel a commission of up to 3% of the gross sales proceeds of any common stock sold through Stifel under the Sales Agreement.
During the three months ended September 30, 2024, the Company sold 100,000 shares of its common stock through Stifel under the Sales Agreement at a weighted average price of $137.85 per share resulting in net proceeds to the Company of $13.3 million, after deducting underwriting discounts and commissions of $0.3 million and offering costs of $0.2 million. During the nine months ended September 30, 2024, the Company sold 232,500 shares of its common stock through Stifel under the Sales Agreement at a weighted average price of $126.93 per share resulting in net proceeds to the Company of $28.4 million, after deducting underwriting discounts and commissions of $0.6 million and deferred offering costs of $0.5 million.
Equity Incentive Plans
The following table summarizes the RSU, performance based restricted stock units ("PRSU"), and multi-year performance restricted stock units ("MYPSU") activity for the three and nine months ended September 30, 2024:
| RSUNumberofShares | Grant DateFairValueper share | PRSUNumberofShares | Grant DateFairValueper share | MYPSUNumberofShares | Grant DateFairValueper share | |
|---|---|---|---|---|---|---|
| Unvested at December 31, 2023 | 1,238,417 | $103.8 | 108,622 | $145.5 | 285,880 | $88.6 |
| Granted | 391,669 | 110.8 | 146,116 | 77.4 | — | — |
| Vested | (229,644) | 86.0 | — | — | — | — |
| Forfeited | (13,170) | 126.0 | (55,532) | 123.6 | — | — |
| Unvested at March 31, 2024 | 1,387,272 | $108.5 | 199,206 | $101.5 | 285,880 | $88.6 |
| Granted | 80,159 | 101.2 | — | — | — | — |
| Vested | (248,988) | 85.7 | — | — | — | — |
| Forfeited | (26,539) | 136.3 | — | — | — | — |
| Unvested at June 30, 2024 | 1,191,904 | $112.1 | 199,206 | $101.5 | 285,880 | $88.6 |
| Granted | 164,236 | 123.8 | 10,838 | 155.6 | — | — |
| Vested | (216,298) | 84.4 | — | — | — | — |
| Forfeited | (17,946) | 126.3 | — | — | — | — |
| Unvested at September 30, 2024 | 1,121,896 | $118.9 | 210,044 | $104.3 | 285,880 | $88.6 |
The following summarizes the number and value of the shares withheld for employee taxes:
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (in thousands, except share data) | ||||
| Shares withheld for taxes | 86,593 | 94,774 | 257,599 | 276,404 |
| Amount withheld for taxes | $12,198 | $11,651 | $32,566 | $30,992 |
In March 2024, the Compensation Committee approved target bonus amounts based on the achievement of revenue and individual performance goals for the fiscal year 2024 (the "2024 Goals"). The awards for the actual payouts are granted in the quarter following the end of the performance period. The target bonuses were granted based on a fixed dollar amount to be settled in RSUs on the vesting date and hence the awards have been classified as liability-based awards until settled. Such expense is included in the non-cash adjustment within stock-based compensation expense on the condensed consolidated cash flow statements. The liability of $2.1 million for 2024 Goals was recorded as accrued expenses and other current liabilities in the condensed consolidated balance sheet as of September 30, 2024.
In March 2024 and August 2024, the Compensation Committee of the Company approved PRSUs for the fiscal year 2024 with performance goals based on the achievement of relative total stockholder return with atwo year and athree year performance period (the "2024 TSR PRSU Goals"). The grant-date fair value of each PRSU was determined using Monte Carlo simulation model. The assumptions used in the Monte Carlo simulation for the March 2024 awards included expected volatility of 74.7%, risk free rate of 4.5%, no expected dividend yield and expected term of 2.8 years. The assumptions used in the Monte Carlo simulation for the August 2024 awards included expected volatility ranging from 60.5% to 71.9%, risk free rate ranging from 3.9% to 4.3%, no expected dividend yield and expected term ranging from 1.4 years to 2.4 years. The Company recognizes the expense related to the 2024 TSR PRSU Goals on a graded-vesting method over the requisite performance period. These grants are included in the PRSU awards granted in the table above.
The Company also operates a bonus plan for certain employees which are based on a fixed dollar amount to be settled in RSUs. These awards are categorized as liability-based awards until settled. Once settled, these awards are reflected as RSU granted in the above table. Such expense is included in the non-cash adjustment within stock-based compensation expense on the condensed consolidated cash flow statements. The liability of $1.0 million was recorded as accrued expenses and other current liabilities in the condensed consolidated balance sheet as of September 30, 2024.
Stock-Based Compensation
The following table presents the detail of stock-based compensation expense amounts included in the condensed consolidated statement of operations for each of the periods presented:
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (in thousands) | ||||
| Equity based awards | ||||
| Cost of revenue | $470 | $725 | $961 | $2,050 |
| Research and development | 8,526 | 7,375 | 25,762 | 24,386 |
| Selling, general and administrative | 11,710 | 10,385 | 35,801 | 29,940 |
| $20,706 | $18,485 | $62,524 | $56,376 | |
| Liability based awards - to be settled in equity | ||||
| Cost of revenue | $25 | $23 | $41 | $51 |
| Research and development | 866 | 481 | 2,220 | 1,484 |
| Selling, general and administrative | 1,215 | 540 | 2,646 | 1,314 |
| $2,106 | $1,044 | $4,907 | $2,849 | |
| Total stock-based compensation expense - equity and liability based | $22,812 | $19,529 | $67,431 | $59,225 |
| Stock-based compensation expense recorded to additional paid-in capital | ||||
| Equity based awards | $20,706 | $18,485 | $62,524 | $56,376 |
| Liability based awards - settled in equity | 1,009 | 831 | 3,633 | 3,117 |
| Stock compensation expense capitalized to inventory | 200 | — | 1,005 | — |
| Total stock-based compensation expense recorded to additional paid-in capital | $21,915 | $19,316 | $67,162 | $59,493 |
The following table presents the unrecognized compensation costs and related weighted average period of recognition as of September 30, 2024:
| Unrecognized Compensation Costs (in millions) | Weighted Average Period of Recognition (in years) | |
|---|---|---|
| RSUs | $122.1 | 2.0 |
| PRSUs | $13.8 | 1.2 |
| MYPSUs | $3.9 | 0.9 |
| Liability-based awards | $3.8 | 0.4 |
Note 7. Income Taxes
The quarterly provision for income taxes is based on applying the estimated annual effective tax rate to the year to date pre-tax income, plus any discrete items. The Company updates its estimate of its annual effective tax rate at the end of each quarterly period. The estimate takes into account annual forecasted income before income taxes, the geographic mix of income before income taxes and any significant permanent tax items.
The following table presents the provision for income taxes and the effective tax rates for the three and nine months ended September 30, 2024 and 2023:
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (in thousands) | ||||
| Loss before income taxes | $(19,196) | $(18,076) | $(74,674) | $(60,395) |
| Income tax benefit (expense) | (119) | (49) | (114) | (142) |
| Effective tax rate | 0.6% | 0.3% | 0.2% | 0.2% |
The Company’s effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in tax jurisdictions with different statutory rates, benefits related to tax credits and the tax impact of non-deductible expenses, existence of full valuation allowance on its deferred tax assets, and other permanent differences between income before income taxes and taxable income.
A valuation allowance is established or maintained when, based on currently available information and other factors, it is more likely than not that all or a portion of the deferred tax assets will not be realized. The Company regularly assesses its valuation allowance against deferred tax assets on a jurisdiction by jurisdiction basis. The Company considers all available positive and negative evidence, including future reversals of temporary differences, projected future taxable income, tax planning strategies and recent financial results. Based on management’s assessment of the realizability of deferred tax assets, the Company continues to maintain a full valuation reserve on its deferred tax assets as of September 30, 2024.
The income tax provision was less than $0.2 million for both the three and nine months ended September 30, 2024 and 2023. The effective tax rate was less than 1% for both the three and nine months ended September 30, 2024 and 2023. The provision for income taxes is primarily related to the foreign subsidiaries’ local country obligations. The U.S. effective tax rate is less than 1% and is due to minimum state tax. There is no federal provision for income taxes as the Company has sufficient carryforward of net operating losses to offset any operating income earned since inception and has projected an operating loss in the current year.
As of September 30, 2024 and December 31, 2023, the Company had $2.3 million and $2.3 million, respectively, of total unrecognized tax benefits. If the Company is able to eventually recognize these uncertain tax positions, none of the unrecognized benefits would reduce the Company’s effective tax rate due to the full valuation allowance on the Company’s deferred tax assets.
The Company’s policy is to record interest and penalties related to unrecognized tax benefits as income tax expense. For the three and nine months ended September 30, 2024 and 2023, the Company recorded immaterial amounts related to the accrual of interest and penalties.
Note 8. Segment, Geographic and Customer Information
The Company operates inone reportable segment related to the sale of Precision Timing solutions to the global electronics industry.
Revenue by geographic area is presented based upon the ship-to location of the customers who purchased the Company’s products, which may be different from the geographic locations of the ultimate end customers. The following table sets forth revenue by country for countries with 10% or more of the Company’s revenue during any of the periods presented:
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (in thousands) | ||||
| Taiwan | $20,854 | $13,181 | $42,465 | $29,085 |
| Hong Kong | 17,010 | 8,673 | 42,546 | 21,519 |
| United States | 3,795 | 3,868 | 11,428 | 15,493 |
| Singapore | 5,291 | 3,110 | 11,759 | 10,558 |
| Other | 10,748 | 6,688 | 26,388 | 24,935 |
| Total | $57,698 | $35,520 | $134,586 | $101,590 |
The following table sets forth the Company’s total property and equipment attributable to operations by country as of the periods presented:
| As of | ||
|---|---|---|
| September 30, 2024 | December 31, 2023 | |
| (in thousands) | ||
| United States | $38,824 | $22,540 |
| Malaysia | 13,444 | 14,471 |
| Taiwan | 7,682 | 6,520 |
| Other | 9,739 | 11,154 |
| $69,689 | $54,685 | |
Note 9. Commitments and Contingencies
Legal Matters
From time to time, the Company may be a party to various litigation claims in the normal course of business. Legal fees and other costs associated with such actions are expensed as incurred. The Company assesses, in conjunction with legal counsel, the need to record a liability for litigation and contingencies. Accrual estimates are recorded when and if it is determined that such a liability for litigation and contingencies are both probable and reasonably estimable. We did not have any amounts accrued towards these matters as of September 30, 2024
Indemnification
The Company is a party to a variety of agreements pursuant to which it may be obligated to indemnify other parties to such agreements with respect to certain matters. Typically, these obligations arise in the context of contracts that the Company has entered into, under which the Company customarily agrees to hold the other party harmless against losses arising from a breach of representations and covenants or terms and conditions related to such matters as the sale and/or delivery of its products, title to assets sold, certain intellectual property claims, defective products, and specified environmental matters. Further, the Company’s obligations under these agreements may be limited in terms of time, amount, or the scope of its responsibility and in some instances, the Company may have recourse against third-parties for certain payments made under these agreements. It is not possible to predict the maximum potential amount of future payments under these agreements due to the conditional nature of the Company’s obligations and the unique facts and circumstances involved in each particular agreement. Historically, the Company has had no material indemnification claims under these agreements.
Purchase Commitments
The Company purchases components from a variety of suppliers and uses several contract manufacturers to provide manufacturing services for its products. During the normal course of business, in order to manage manufacturing lead times and to help ensure adequate component supply, the Company enters into agreements with the Company’s contract manufacturers and suppliers that allow them to procure inventory based upon criteria as defined by the Company. In addition, the Company has a multi-year agreement to purchase minimum quantities of MEMS wafers and is responsible for research and development, tooling, and samples cost under the agreement. A portion of the Company’s reported purchase commitments arising from these agreements consists of firm, non-cancelable purchase commitments. In certain instances, these agreements allow the Company the option to cancel, reschedule, and adjust the Company’s requirements based on its business needs prior to when production starts. However, in situations where the Company is unable to cancel, reschedule, or adjust the purchase commitment due to changing customer demand, excess inventories could result in material inventory provisions. Total future non-cancelable purchase commitments as of September 30, 2024 were as follows:
| (in thousands) | |
|---|---|
| Remainder of 2024 | $2,872 |
| 2025 | 8,695 |
| 2026 | 8,317 |
| 2027 | 1,419 |
| 2028 | 525 |
| Total | $21,828 |
Note 10. Net Loss Per Share
The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (in thousands, except per share data) | ||||
| Net loss attributable to common stockholders | $(19,315) | $(18,125) | $(74,788) | $(60,537) |
| Weighted-average shares outstanding | ||||
| Weighted average shares used to compute basic net loss per share | 23,237 | 22,326 | 23,001 | 22,065 |
| Dilutive effect of employee equity incentive plans | — | — | — | — |
| Weighted average shares used to compute diluted net loss per share | 23,237 | 22,326 | 23,001 | 22,065 |
| Net loss attributable to common stockholders per share, basic | $(0.83) | $(0.81) | $(3.25) | $(2.74) |
| Net loss attributable to common stockholders per share, diluted | $(0.83) | $(0.81) | $(3.25) | $(2.74) |
Potential dilutive securities include dilutive common shares from share-based awards attributable to the assumed exercise of restricted stock unit awards using the treasury stock method. Under the treasury stock method, potential common shares outstanding are not included in the computation of diluted net income per share if their effect is anti-dilutive.
Anti-dilutive potential shares from share-based awards are excluded from the calculation of diluted earnings per share if either their exercise price exceeded the average market price during the period, or the share-based awards were determined to be anti-dilutive based on applying the treasury stock method. During the three months ended September 30, 2024 and 2023, the Company had 537,475 and 960,848 potential shares from share-based awards that are anti-dilutive, respectively. During the nine months ended September 30, 2024 and 2023, the Company had 582,264 and 1,143,888 potential shares from share-based awards that are anti-dilutive, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.